NovaBay Pharmaceuticals, Inc. (NBY) Financials

NBY Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 12.9 million 5.8 million
2023-06-30 16.0 million 7.4 million
2023-03-31 14.8 million 5.9 million
2022-12-31 16.4 million 5.8 million

NBY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -365000 62000
2023-06-30 -1.8 million 64000
2023-03-31 -1.6 million 75000
2022-12-31 -1.2 million 90000

NBY Net Income

No data available :(

NBY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 3.5 million - 1.7 million
2023-06-30 4.4 million - 1.9 million
2023-03-31 3.7 million - 2.0 million
2022-12-31 5.4 million - 2.0 million

NBY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 4.7 million
2023-06-30 3.2 million
2023-03-31 2.0 million
2022-12-31 1.9 million

NBY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 2000 11000 1.2 million 1.7 million
2023-06-30 2000 27000 1.9 million 1.7 million
2023-03-31 13000 26000 2.0 million 1.6 million
2022-12-31 32000 66000 2.4 million 1.9 million

NBY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 3.3 million 1.4 million
2023-06-30 4.6 million 2.3 million
2023-03-31 3.1 million 1.2 million
2022-12-31 3.6 million 1.9 million

NBY

Price: $0.08

52 week price:
0.07
1.95

Earnings Per Share: -7.05 USD

P/E Ratio: -0.02

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 100900

Market Capitalization: 3.0 million

Links: